Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease

NCT05161715 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Early Alzheimer's Disease

Interventions

DRUG: Obicetrapib

Sponsor

NewAmsterdam Pharma